Lack of gp130 expression in hepatocytes promotes liver injury
- PMID: 12891556
- DOI: 10.1016/s0016-5085(03)00901-6
Lack of gp130 expression in hepatocytes promotes liver injury
Abstract
Background & aims: Interleukin 6 (IL-6) contributes via its signal transducer gp130 to the acute phase response (APR) in hepatocytes. Recent studies indicated that IL-6 is involved in the regulation of different pathophysiologic conditions of the liver. To define the IL-6-dependent intracellular pathways more specifically, we generated a hepatocyte-specific gp130 knockout mouse.
Methods: Hepatocyte-specific gp130-deficient mice were generated using the Cre-loxP system. Expression of the Cre recombinase was under the control of a hepatocyte-specific control element. Adult mice were challenged with IL-6, oncostatin M (OSM), and LPS.
Results: Cre expression started at day 10.5 postconception, and a complete deletion of gp130 in hepatocytes was found at day 14 during liver development. The adult liver of these mice showed no abnormalities; however, after IL-6 and OSM stimulation, gp130-dependent pathways (STAT3, APR gene expression) were completely blocked in the liver of these animals. Additionally, challenging hepatocyte-specific gp130 knockout animals with lipopolysaccharides (LPS) lead to an onset of acute liver injury with an increase of hepatocyte apoptosis associated with elevated tumor necrosis factor alpha (TNF-alpha) serum levels and reduced nuclear factor kappaB (NF-kappaB) activation in hepatocytes.
Conclusions: Our findings demonstrate that gp130 is of minor relevance for embryonal development of hepatocytes. However, the molecule has an essential role in controlling acute phase gene expression and provides hepatocellular protection after LPS challenge.
Similar articles
-
The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.J Clin Invest. 2005 Apr;115(4):860-9. doi: 10.1172/JCI23640. Epub 2005 Mar 3. J Clin Invest. 2005. PMID: 15761498 Free PMC article.
-
Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.Hepatology. 2003 Jul;38(1):218-29. doi: 10.1053/jhep.2003.50268. Hepatology. 2003. PMID: 12830005
-
Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration.J Biol Chem. 2003 Mar 28;278(13):11281-8. doi: 10.1074/jbc.M208470200. Epub 2002 Dec 30. J Biol Chem. 2003. PMID: 12509437
-
Mediators of inflammation and acute phase response in the liver.Cell Mol Biol (Noisy-le-grand). 2001 Jun;47(4):661-73. Cell Mol Biol (Noisy-le-grand). 2001. PMID: 11502073 Review.
-
_targeted disruption of the IL-6 related genes: gp130 and NF-IL-6.Immunol Rev. 1995 Dec;148:221-53. doi: 10.1111/j.1600-065x.1995.tb00100.x. Immunol Rev. 1995. PMID: 8825289 Review. No abstract available.
Cited by
-
Acute and chronic effects of IL-22 on acetaminophen-induced liver injury.J Immunol. 2014 Sep 1;193(5):2512-8. doi: 10.4049/jimmunol.1400588. Epub 2014 Jul 25. J Immunol. 2014. PMID: 25063867 Free PMC article.
-
The gp130/STAT3-endoplasmic reticulum stress axis regulates hepatocyte necroptosis in acute liver injury.Croat Med J. 2023 Jun 30;64(3):149-163. doi: 10.3325/cmj.2023.64.149. Croat Med J. 2023. PMID: 37391912 Free PMC article.
-
Endotoxin Inflammatory Action on Cells by Dysregulated-Immunological-Barrier-Linked ROS-Apoptosis Mechanisms in Gut-Liver Axis.Int J Mol Sci. 2024 Feb 20;25(5):2472. doi: 10.3390/ijms25052472. Int J Mol Sci. 2024. PMID: 38473721 Free PMC article.
-
The two facets of gp130 signalling in liver tumorigenesis.Semin Immunopathol. 2021 Aug;43(4):609-624. doi: 10.1007/s00281-021-00861-0. Epub 2021 May 28. Semin Immunopathol. 2021. PMID: 34047814 Free PMC article. Review.
-
Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model.Cell Death Dis. 2015 Mar 5;6(3):e1667. doi: 10.1038/cddis.2014.590. Cell Death Dis. 2015. PMID: 25741592 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
